Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immune-Mediated Necrotizing Myopathy”

18 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 18 of 18 results

Early research (Phase 1)Not Yet RecruitingNCT07676266
What this trial is testing

C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard Therapy

Who this might be right for
Multiple Sclerosis (MS)Myasthenia Gravis (MG)Neuromyelitis Optica Spectrum Disorder+3 more
The Affiliated Hospital of Qingdao University 18
Not applicableStudy completedNCT04486261
What this trial is testing

High-intensity Strength Training in Myositis

Who this might be right for
MyositisDermatomyositisPolymyositis+1 more
Rigshospitalet, Denmark 34
Not applicableUnknownNCT04295785
What this trial is testing

Juvenile Autoimmune Necrotizing Myopathies

Who this might be right for
Immune-Mediated Necrotizing Myopathy
Central Hospital, Nancy, France 10
Early research (Phase 1)Looking for participantsNCT06371417
What this trial is testing

Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)

Who this might be right for
Antiphospholipid Syndrome (APS)Bullous Pemphigoid (BP)Behçet's Syndrome (BS)+3 more
Chugai Pharmaceutical 144
Large-scale testing (Phase 3)Study completedNCT05523167
What this trial is testing

Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathy.

Who this might be right for
Active Idiopathic Inflammatory MyopathyMyositisDermatomyositis+3 more
argenx 265
Large-scale testing (Phase 3)Looking for participantsNCT06154252
What this trial is testing

RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy

Who this might be right for
Idiopathic Inflammatory MyopathyDermatomyositisAnti-Synthetase Syndrome+5 more
Cabaletta Bio 74
Not applicableLooking for participantsNCT07374107
What this trial is testing

MIHRA - Patient-Rooted Insights for Shaping Myositis Science (PRISMS)

Who this might be right for
IBMIIMMyositis+9 more
Myositis International Health & Research Collaborative Alliance Foundation 700
Testing effectiveness (Phase 2)Active Not RecruitingNCT06665256
What this trial is testing

Phase 2 Study of Rapcabtagene Autoleucel in Myositis

Who this might be right for
Idiopathic Inflammatory Myopathies
Novartis Pharmaceuticals 21
Large-scale testing (Phase 3)Enrolling By InvitationNCT05979441
What this trial is testing

Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Active Idiopathic Inflammatory Myopathy

Who this might be right for
MyositisActive Idiopathic Inflammatory MyopathyDermatomyositis+3 more
argenx 240
Early research (Phase 1)Looking for participantsNCT06249438
What this trial is testing

C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard Therapy

Who this might be right for
Systemic Lupus Erythematosus (SLE)Immune-mediated Necrotizing Myopathy (IMNM)Neuromyelitis Optica Spectrum Disorders (NMOSD)+3 more
RenJi Hospital 30
Large-scale testing (Phase 3)Study completedNCT02971683
What this trial is testing

Trial to Evaluate the Efficacy and Safety of Abatacept in Combination With Standard Therapy Compared to Standard Therapy Alone in Improving Disease Activity in Adults With Active Idiopathic Inflammatory Myopathy

Who this might be right for
PolymyositisDermatomyositisAutoimmune Necrotizing Myopathy+2 more
Bristol-Myers Squibb 149
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07752264
What this trial is testing

A Phase I/II Study of Eque-cel in Subjects Withimmune-mediated Necrotizing Myopathy

Who this might be right for
Refractory Immune-mediated Necrotizing Myopathy
Nanjing IASO Biotechnology Co., Ltd. 27
Testing effectiveness (Phase 2)WithdrawnNCT04450654
What this trial is testing

Monotherapy IVIG Gamunex-C for HMG-CoA Reductase Auto-Antibody Positive Necrotizing Myopathy Treatment (The MIGHT Trial)

Who this might be right for
Immune-Mediated Necrotizing Myopathy
University of Washington
Testing effectiveness (Phase 2)Looking for participantsNCT06599697
What this trial is testing

The MIGHT Trial - An Exploratory Clinical Trial of IVIG in Anti-HMGCR Immune Mediated Necrotizing Myopathy

Who this might be right for
Anti-3-hydroxy-3-methylglutaryl-CoA Reductase (HMGCR) Immune-Mediated Necrotizing Myopathy
University of Alabama at Birmingham 12
Large-scale testing (Phase 3)Active Not RecruitingNCT05832034
What this trial is testing

Add-on Intravenous Immunoglobulins in Early Myositis

Who this might be right for
Inflammatory Myopathy, IdiopathicDermatomyositisAntisynthetase Syndrome+3 more
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 44
Testing effectiveness (Phase 2)Ended earlyNCT04025632
What this trial is testing

Safety and Efficacy Study of Zilucoplan in Subjects With Immune-Mediated Necrotizing Myopathy

Who this might be right for
Immune Mediated Necrotizing Myopathy
Ra Pharmaceuticals 27
Early research (Phase 1)Enrolling By InvitationNCT06723106
What this trial is testing

Phase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial)

Who this might be right for
Antiphospholipid Syndrome (APS)Bullous Pemphigoid (BP)Behçet's Syndrome (BS)+3 more
Chugai Pharmaceutical 144
Testing effectiveness (Phase 2)Looking for participantsNCT07103746
What this trial is testing

Ublituximab in Autoantibody Positive Immune Mediated Necrotizing Myopathy

Who this might be right for
Autoimmune Disorders
National Institute of Allergy and Infectious Diseases (NIAID) 30